Potential clinical applications of placental stem cells for use in fetal therapy of birth defects
- 1 November 2017
- journal article
- review article
- Published by Elsevier BV in Placenta
- Vol. 59, 107-112
- https://doi.org/10.1016/j.placenta.2017.05.010
Abstract
No abstract availableFunding Information
- California Institute for Regenerative Medicine (PC1-08103)
- Shriners Hospital for Children research (8512)
- March of Dimes Foundation Basil O'Connor Starter Scholar Research (5FY1682)
This publication has 64 references indexed in Scilit:
- Inpatient Hospitalization Costs Associated with Birth Defects Among Persons of All Ages — United States, 2013Morbidity and Mortality Weekly Report (MMWR), 2017
- Heterogeneity of proangiogenic features in mesenchymal stem cells derived from bone marrow, adipose tissue, umbilical cord, and placentaStem Cell Research & Therapy, 2016
- How far are we from the clinical use of placental-derived mesenchymal stem cells?Expert Opinion on Biological Therapy, 2015
- Impact of Aging on the Regenerative Properties of Bone Marrow-, Muscle-, and Adipose-Derived Mesenchymal Stem/Stromal CellsPLOS ONE, 2014
- Fetal SurgeryObstetrics & Gynecology, 2014
- A Comparative Study on Culture Conditions and Routine Expansion of Amniotic Fluid-Derived Mesenchymal Progenitor CellsFetal Diagnosis and Therapy, 2013
- Mesenchymal Stromal Cell Characteristics Vary Depending on Their OriginStem Cells and Development, 2013
- Expression and co-expression of surface markers of pluripotency on human amniotic cells cultured in different growth mediaGinekologia Polska, 2013
- Congenital anomaliesOrganogenesis, 2012
- Stem Cell and Precursor Cell TherapyNeuroMolecular Medicine, 2002